The Continuum of Care for Patients with Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) VL

Communication for Optimal Care in Patients Selected for Triplet Therapy Between Urology and Community Oncology - Vahan Kassabian & Sreekanth Reddy

Details
Zach Klaassen engages with Vahan Kassabian and Sreekanth to discuss the continuum of care for patients with metastatic hormone-sensitive prostate cancer, particularly in the context of triplet therapy based on the ARASENS data. The conversation reveals their longstanding professional relationship, developed through mutual patients and a shared interest in urological oncology. They discuss the logi...

Sharing Care within Private Clinics for Patients with Newly Diagnosed mHSPC - David Morris & Benjamin Garmezy

Details
Alicia Morgans hosts a multidisciplinary discussion with David Morris and Benjamin Garmezy focusing on the treatment of newly diagnosed metastatic hormone-sensitive prostate cancer (mHSPC). Dr. Morris highlights the increasing trend of referring patients with high-volume Gleason 8 disease and metastatic cancer to tertiary care centers. He emphasizes the importance of early discussions about intens...